[HTML][HTML] Role of epidermal growth factor receptor in lung cancer and targeted therapies

TC Liu, X Jin, Y Wang, K Wang - American Journal of Cancer …, 2017 - ncbi.nlm.nih.gov
Lung cancer is the foremost cause of cancer-related deaths world-wide. Both, the major
forms of lung cancer, Non-small cell lung cancer (NSCLC) and Small cell lung cancers …

Surgery for local and locally advanced non‐small cell lung cancer

R Manser, G Wright, D Hart, G Byrnes… - Cochrane Database …, 2005 - cochranelibrary.com
Background Surgical resection (usually lobectomy) is considered the treatment of choice for
many individuals with early stage non‐small cell lung cancer (NSCLC). However much of …

[HTML][HTML] Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi …

H Onishi, H Shirato, Y Nagata, M Hiraoka… - Journal of thoracic …, 2007 - Elsevier
Introduction Hypofractionated stereotactic radiotherapy (HypoFXSRT) has recently been
used for the treatment of small lung tumors. We retrospectively analyzed the treatment …

Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study

H Onishi, T Araki, H Shirato, Y Nagata, M Hiraoka… - Cancer, 2004 - Wiley Online Library
BACKGROUND Stereotactic irradiation (STI) has been actively performed using various
methods to achieve better local control of Stage I nonsmall cell lung carcinoma (NSCLC) in …

Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end …

CM Mery, AN Pappas, R Bueno, YL Colson, P Linden… - Chest, 2005 - Elsevier
Study objectives To determine the effect of age and type of surgery on long-term survival in
patients with early-stage non-small cell lung cancer (NSCLC). Design and patients A total of …

Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic …

P Baumann, J Nyman, I Lax, S Friesland, M Hoyer… - Acta …, 2006 - Taylor & Francis
We reviewed results of SBRT treatment of 138 patients with medically inoperable stage I
NSCLC treated during 1996–2003 at five different centres in Sweden and Denmark. Mean …

Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer

SJ Kim, ZN Rabbani, MW Dewhirst, Z Vujaskovic… - Lung cancer, 2005 - Elsevier
Endogenous hypoxia markers have been studied as prognostic indicators because they
appear to be associated with tumor aggressiveness. This study was undertaken to compare …

Selective mediastinal lymphadenectomy for clinico-surgical stage I non–small cell lung cancer

M Okada, T Sakamoto, T Yuki, T Mimura… - The Annals of thoracic …, 2006 - Elsevier
BACKGROUND: Improved radiologic imaging provides earlier detection of non–small cell
lung cancer, but controversy exists regarding the need for complete lymph node dissection …

Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials

G Wright, RL Manser, G Byrnes, D Hart, DA Campbell - Thorax, 2006 - thorax.bmj.com
Background: Surgery is considered the treatment of choice for patients with resectable stage
I and II (and some patients with stage IIIA) non-small cell lung cancer (NSCLC), but there …

[HTML][HTML] Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable …

KL Stephans, T Djemil, CA Reddy, SM Gajdos… - Journal of Thoracic …, 2009 - Elsevier
Background: To assess for variables predicting pulmonary function test (PFT) changes after
stereotactic body radiotherapy (SBRT) for medically inoperable stage I lung cancer …